How Ezetimibe Lowers LDL Cholesterol
Ezetimibe reduces LDL cholesterol by blocking its absorption in the small intestine. It selectively inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein on enterocyte brush borders, which normally transports dietary and biliary cholesterol into intestinal cells for uptake into the bloodstream. By preventing this uptake, less cholesterol reaches the liver, prompting the liver to increase LDL receptor expression on its surface. These receptors pull more LDL particles from circulation, clearing them from blood.[1][2]
Why Doesn't It Affect Other Lipids Much?
Ezetimibe primarily targets cholesterol absorption without broadly impacting fat or triglyceride uptake. It spares proteins like MTP (microsomal triglyceride transfer protein), so it lowers LDL by 15-25% on average but has minimal effects on HDL (+1-3%) or triglycerides (-5-10%). This selectivity stems from NPC1L1's role in cholesterol-specific transport.[1][3]
How It Pairs with Statins
Combined with statins, ezetimibe amplifies LDL reduction by 20-25% beyond statins alone. Statins cut hepatic cholesterol synthesis, enhancing the liver's LDL receptor upregulation triggered by ezetimibe's absorption block. Trials like IMPROVE-IT showed this combo cuts cardiovascular events in high-risk patients.[2][4]
When Does It Start Working and How Long Does It Last?
Peak LDL lowering occurs within 1-2 weeks of daily 10mg dosing. Its half-life is about 22 hours, supporting once-daily use, with effects persisting as long as treatment continues. No dose adjustment needed for most kidney or liver issues, except severe cases.[1][3]
Common Side Effects Patients Report
Most tolerate it well, with side effects like diarrhea, fatigue, or muscle pain in under 5%—often milder than statins. Rare risks include liver enzyme elevations or allergic reactions. It's pregnancy category C, so avoided in pregnancy.[3][4]
Sources
[1]: DrugPatentWatch.com - Ezetimibe
[2]: FDA Label - Zetia (ezetimibe)
[3]: PubMed - Mechanism of ezetimibe
[4]: NEJM - IMPROVE-IT Trial